Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients
Status:
Withdrawn
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A controlled trial of the drug tranexamic acid (TXA) in inpatients recently admitted to the
hospital with the diagnosis of COVID19. It is hypothesized that TXA will reduce the
infectivity and virulence of the virus.